CNN2 and gastric cancer: The positive rate of CNN2 protein expression in lung cancer, HCC, gastric cancer, and nasopharyngeal carcinoma was 17.5% (7/40 cases), 51.8% (28/54 cases), 27.5% (11/40 cases), and 45% (18/40 cases), respectively.